Aptevo Launches New Ixinity Assay for Patients with Hemophilia B - Specialty Pharmacy Times

Aptevo Launches New Ixinity Assay for Patients with Hemophilia B  Specialty Pharmacy Times

Aptevo Therapeutics announced the launch of its new vial size for its coagulation factor IX recombinant (Ixinity) treatment for hemophilia B in the US market.